Table 2.
| ||||||
Groups | Endometrial Epithelium (µm) | Lumen (µm) | Gland (N/HPF)* | Vessel (N/HPF)* | Endometrial Diameter (µm) | Stromal Cell (N/HPF)* |
C | 24.4 ± 5.01 | 137.1 ± 13.99 | 10.96 ± 2.43 | 14.14 ± 2.74 | 609.7 ± 137.5 | 134.9 ± 11.97 |
SH | 21.1 ± 2.81 | 122.2 ± 28.84 | 10.13 ± 1.65 | 12.76 ± 1.61 | 553.6 ± 143.4 | 133.4 ± 25.92 |
B1 | 18.86 ± 1.40 | 173 ± 40.11 | 7.33 ± 1.99 | 7.18 ± 1.48 | 417.2 ± 95.3 | 96.25 ± 18.71 |
B2 | 15.11 ± 4.07 | 213.9 ± 40.63 | 6.77 ± 1.71 | 6.93 ± 1.53 | 320.4 ± 69.87 | 96.13 ± 11.41 |
B5 | 13.7 ± 1.09 | 280.4 ± 52.34 | 7.53 ± 2.24 | 7.49 ± 2.28 | 439.2 ± 35.18 | 87.97 ± 12.82 |
Note: The values are as mean SD (p 0.05);
*: Number of cross-sections per high power field (HPF);
a: Comparing diverse BaP-receiving groups with the control group, b: Comparing B5 and B2 with B1, and c: B5 with B2;
C: The control group received normal saline;
SH: The Sham group receiving corn oil;
B1: The group receiving BaP as 100 µg/kg;
B2: The group receiving BaP as 200 µg/kg;
B5: The group receiving BaP as 500 µg/kg.